NCT03402087View on ClinicalTrials.gov

A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

March 20, 2018

Study Completion Date

March 25, 2018

Conditions
LupusPsoriatic Arthritis
Interventions
DRUG

Methotrexate

Specified dose on specified days

DRUG

Leucovorin

Specified dose on specified days

DRUG

BMS-986165

Specified dose on specified days

Trial Locations (1)

9728 NZ

PRA Health Sciences, Groningen

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY